EDAP TMS S.A. Net Assets
EDAP TMS S.A. net assets. Based on the latest financial reports, EDAP TMS S.A. (FOCL) has net assets worth $-3.23 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($74.55 Million) and total liabilities ($77.77 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore EDAP TMS S.A. equity growth rate to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.23 Million |
| % of Total Assets | -4.33% |
| Annual Growth Rate | -1.41% |
| 5-Year Change | -65.9% |
| 10-Year Change | -25.45% |
| Growth Volatility | 32.04 |
Net Assets of EDAP TMS S.A. (2006–2025)
Net assets of EDAP TMS S.A. from 2006 to 2025. This chart illustrates how EDAP TMS S.A.'s net assets have evolved over time, based on quarterly financial data. See FOCL equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for EDAP TMS S.A. (2006–2025)
The table below shows the annual net assets of EDAP TMS S.A. from 2006 to 2025. For live market cap and overall valuation, see how much is EDAP TMS S.A. worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $19.41 Million | -54.16% |
| 2024-12-31 | $42.35 Million | -32.65% |
| 2023-12-31 | $62.88 Million | -17.75% |
| 2022-12-31 | $76.45 Million | +34.31% |
| 2021-12-31 | $56.92 Million | +70.13% |
| 2020-12-31 | $33.46 Million | +4.84% |
| 2019-12-31 | $31.91 Million | +7.36% |
| 2018-12-31 | $29.73 Million | -5.51% |
| 2017-12-31 | $31.46 Million | +20.81% |
| 2016-12-31 | $26.04 Million | +63.43% |
| 2015-12-31 | $15.93 Million | -13.83% |
| 2014-12-31 | $18.49 Million | +44.54% |
| 2013-12-31 | $12.79 Million | +18.90% |
| 2012-12-31 | $10.76 Million | -4.89% |
| 2011-12-31 | $11.31 Million | -5.26% |
| 2010-12-31 | $11.94 Million | -33.84% |
| 2009-12-31 | $18.05 Million | -24.47% |
| 2008-12-31 | $23.90 Million | +12.73% |
| 2007-12-31 | $21.20 Million | -16.71% |
| 2006-12-31 | $25.45 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to EDAP TMS S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12487762800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
EDAP TMS S.A. Net Assets Breakdown (December 2025)
EDAP TMS S.A. net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $6.07 Million | 31.27% |
| Other Comprehensive Income | $-8.34 Million | -42.95% |
| Other Components | $150.29 Million | 774.20% |
| Total Equity | $19.41 Million | 100.00% |
EDAP TMS S.A. Competitors by Market Cap
The table below lists competitors of EDAP TMS S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vivozon Healthcare Inc
KQ:082800
|
$156.18 Million |
|
WEST RED LAKE GOLD MINES
F:UJ0
|
$156.18 Million |
|
Formuepleje Limittellus
CO:FPILIM
|
$156.21 Million |
|
Dynacor Gold Mines Inc.
TO:DNG
|
$156.25 Million |
|
Chiang Mai Ram Medical Business Public Company Limited
BK:CMR
|
$156.08 Million |
|
Map Boga Adiperkasa Tbk PT
JK:MAPB
|
$156.01 Million |
|
POLARIS RENEWABLE ENERGY
F:N4T
|
$155.99 Million |
|
Powerwell Holdings Bhd
KLSE:0217
|
$155.96 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EDAP TMS S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 42,347,808 to 19,413,000, a change of -22,934,808 (-54.2%).
- Net loss of 29,336,493 reduced equity.
- Other comprehensive income decreased equity by 3,269,263.
- Other factors increased equity by 9,670,948.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-29.34 Million | -151.12% |
| Other Comprehensive Income | $-3.27 Million | -16.84% |
| Other Changes | $9.67 Million | +49.82% |
| Total Change | $- | -54.16% |
Book Value vs Market Value Analysis
This analysis compares EDAP TMS S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.06x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.57x to 8.06x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | $2.66 | $4.18 | x |
| 2007-12-31 | $2.18 | $4.18 | x |
| 2008-12-31 | $2.47 | $4.18 | x |
| 2009-12-31 | $1.71 | $4.18 | x |
| 2010-12-31 | $0.92 | $4.18 | x |
| 2011-12-31 | $0.85 | $4.18 | x |
| 2012-12-31 | $0.61 | $4.18 | x |
| 2013-12-31 | $0.62 | $4.18 | x |
| 2014-12-31 | $0.78 | $4.18 | x |
| 2015-12-31 | $0.63 | $4.18 | x |
| 2016-12-31 | $0.88 | $4.18 | x |
| 2017-12-31 | $1.04 | $4.18 | x |
| 2018-12-31 | $0.98 | $4.18 | x |
| 2019-12-31 | $1.04 | $4.18 | x |
| 2020-12-31 | $1.10 | $4.18 | x |
| 2021-12-31 | $1.76 | $4.18 | x |
| 2022-12-31 | $2.22 | $4.18 | x |
| 2023-12-31 | $1.70 | $4.18 | x |
| 2024-12-31 | $1.14 | $4.18 | x |
| 2025-12-31 | $0.52 | $4.18 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EDAP TMS S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -151.12%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -41.47%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 4.07x
- Recent ROE (-151.12%) is below the historical average (-31.96%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -17.06% | -17.01% | 0.60x | 1.68x | $-6.89 Million |
| 2007 | -35.31% | -24.45% | 0.47x | 3.10x | $-9.61 Million |
| 2008 | 9.82% | 6.99% | 0.55x | 2.55x | $-42.86K |
| 2009 | -60.06% | -31.27% | 0.60x | 3.21x | $-12.64 Million |
| 2010 | -140.94% | -54.81% | 0.64x | 4.04x | $-18.02 Million |
| 2011 | -11.61% | -4.21% | 0.75x | 3.70x | $-2.44 Million |
| 2012 | -89.74% | -28.73% | 0.84x | 3.73x | $-10.73 Million |
| 2013 | -52.21% | -20.85% | 0.86x | 2.89x | $-7.96 Million |
| 2014 | -3.71% | -1.91% | 0.91x | 2.12x | $-2.51 Million |
| 2015 | -11.79% | -5.17% | 0.85x | 2.67x | $-3.42 Million |
| 2016 | 16.48% | 10.79% | 0.80x | 1.91x | $1.67 Million |
| 2017 | -2.54% | -1.91% | 0.72x | 1.86x | $-3.79 Million |
| 2018 | -1.40% | -0.86% | 0.83x | 1.95x | $-3.25 Million |
| 2019 | 5.51% | 3.37% | 0.84x | 1.94x | $-1.38 Million |
| 2020 | -6.05% | -4.09% | 0.70x | 2.10x | $-5.15 Million |
| 2021 | 1.45% | 1.59% | 0.59x | 1.54x | $-4.86 Million |
| 2022 | -4.03% | -5.32% | 0.54x | 1.41x | $-10.73 Million |
| 2023 | -36.41% | -35.05% | 0.65x | 1.61x | $-29.18 Million |
| 2024 | -48.58% | -29.66% | 0.78x | 2.10x | $-24.81 Million |
| 2025 | -151.12% | -41.47% | 0.90x | 4.07x | $-31.28 Million |
Industry Comparison
This section compares EDAP TMS S.A.'s net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,371,934,292
- Average return on equity (ROE) among peers: 11.54%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EDAP TMS S.A. (FOCL) | $-3.23 Million | -17.06% | N/A | $156.12 Million |
| Accendra Health Inc (ACH) | $960.04 Million | 11.33% | 1.83x | $19.43 Million |
| Akso Health Group ADR (AHG) | $12.29 Million | -137.15% | 3.13x | $807.33 Million |
| Cardinal Health Inc (CAH) | $6.26 Billion | 19.42% | 3.82x | $43.01 Billion |
| Cencora Inc. (COR) | $786.74 Million | 191.82% | 84.29x | $61.32 Billion |
| Cosmos Health Inc. (COSM) | $-3.32 Million | 0.00% | 0.00x | $16.11 Million |
| EDAP TMS SA (EDAP) | $12.58 Million | -61.74% | 2.21x | $154.80 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.41 Million | 82.70% | 1.73x | $143.05 Million |
| Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) | $9.58 Million | -11.85% | 0.34x | $5.95 Million |
| Henry Schein Inc (HSIC) | $4.31 Billion | 9.33% | 0.80x | $7.86 Billion |
About EDAP TMS S.A.
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more